PSY21 COST-EFFECTIVENESS ANALYSIS OF EMICIZUMAB FOR THE TREATMENT OF PATIENTS WITH HAEMOPHILIA A WITH INHIBITORS IN PORTUGAL
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2649
https://www.valueinhealthjournal.com/article/S1098-3015(19)35027-2/fulltext
Title :
PSY21 COST-EFFECTIVENESS ANALYSIS OF EMICIZUMAB FOR THE TREATMENT OF PATIENTS WITH HAEMOPHILIA A WITH INHIBITORS IN PORTUGAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)35027-2&doi=10.1016/j.jval.2019.09.2649
First page :
Section Title :
Open access? :
No
Section Order :
12327